| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Alternative > Cholesterol - Seven Reasons Why It's Good For You |
|
Advice Pool - Cholesterol - Seven Reasons Why It's Good For You
1.Did you know that “it has never been proven that high cholesterol contributes to heart disease? Therefore, drugs that lower cholesterol have no benefit for the heart.” So says Dr. Bruce West, cardiologi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product st from Monterey, CA. Having treated 30,000 patients, he has concluded that the fortunate ones are the ones who have not been given cholesterol lowering drugs. 2. Did you know that your brain is half cho ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in esterol? And that cholesterol lowering drugs prevent your brain from this supply of cholesterol that is necessary for the brain to function properly? Could this explain why Alzheimer's and Dementia have b lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. come so widespread in our country? And the medical community is now pushing to lower the accepted level of cholesterol below the already low standards that the drug company researchers had previously set. here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe 3. Did you know that when you eat sugar, your body produces insulin to help you use or store the sugar, but if there is more insulin in the blood vessels than is needed to digest the sugar, the insulin i d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ritates the blood vessel lining causing deterioration? When that happens, the body sends LDL cholesterol to mend the spot. After that has happened repeatedly, the amount of buildup in the blood vessel (ca ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc led plaque) causes the vessel to become narrow and make the circulation through the vessel difficult and may even cause a blockage, or “heart attack”. The cholesterol is not the culprit. Instead, choleste easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi rol is acting as a bandage to repair an injury. The secret to preventing or removing the plaque is not decreasing the amount of cholesterol in the body, but rather, changing the diet so that the surplus i nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically sulin will not be circulating in the blood. 4. Did you know that 75% of the cholesterol in our bodies is produced within the body and that only 25% comes from the food we eat? Doesn’t it seem reasonable and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ hat the Creator must have had a purpose in planning for us to have that much? 5. Did you know that the cholesterol in your skin is transformed into Vitamin D by the sun for healthy bones (unless you wear ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi sunscreen which prevents that from happening)? 6.Did you know that cholesterol is such an important substance that it is contained in practically every cell in the human body? The Honolulu Heart Program ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a tudy, published in the August 2001 issue of The Lancet, states that “the long term persistence of low cholesterol actually increases the risk of death”. Normal cholesterol levels should run between 150 an dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod 250, but the pharmaceutical companies are telling us they should be between 80 and 130. Dr. West, in his September 2005 Health Alert magazine says that that level is “dangerously low. Cholesterol is need cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin d to produce stress hormones and when levels drop below 100, people with cancer or other serious diseases succumb to the disease. If your cholesterol is below 130 and you are on a statin drug, ask your do tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ctor to stop the prescription now.” 7. Did you know that cholesterol levels are either normal or below normal in half of all heart disease patients? In recent studies of people over 75, those with the hi t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel hest cholesterol were the healthiest? ( Dr. Bruce West- Health Alert) Dr. David Williams (writer of the Alternatives magazine) says, “The cholesterol theory of heart disease has been dead for 20 years. I ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust was shot full of holes when scientists showed that the majority of people who suffer heart attacks have normal cholesterol levels. This makes cholesterol-lowering drugs irrelevant and useless. He goes on y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products to say, “I’ve been waving a red flag about cholesterol-lowering drugs since August, 1991, when I first discovered they are not only ineffective, but potentially deadly. (They can rob the heart of an impor . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ant nutrient, CoQ10, that powers its beating.)
“Meanwhile, 13 million people in this country remain on cholesterol drugs, and millions more are being urged to start taking them. It will be a long time b elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip fore an official about-face comes. Tragically, hundreds of thousands of people will go to their deaths following this old-school advice in the false belief they’re being protected.” Posted by Muryal Brau tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Inside A Company's News Release, Part Two How to Find Affordable Car Insurance in Connecticut Considerations To Keep in Mind When Choosing A College
|